Trends in endpoint selection in clinical trials of advanced breast cancer-Reference-Cited by-同舟云学术

Trends in endpoint selection in clinical trials of advanced breast cancer

Published:2016-09-01 Issue:11 Volume:142 Page:2403-2413
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Song Seung Yeon,Seo Heenam,Kim Gyungjin,Kim Ah Rong,Kim Eun Young

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-016-2221-5.pdf

Reference61 articles.

1. American Cancer Society (2015) Cancer Facts & Figures 2015. American Cancer Society, Inc. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf . Accessed 23 Feb 2015

2. Becker JE, Krumholz HM, Ben-Josef G, Ross JS (2014) Reporting of results in ClinicalTrials.gov and high-impact journals JAMA 311:1063–1065 doi: 10.1001/jama.2013.285634

3. Booth CM, Eisenhauer EA (2012) Progression-free survival: meaningful or simply measurable? J Clin Oncol 30:1030–1033. doi: 10.1200/jco.2011.38.7571

4. Bottomley A (2002) The cancer patient and quality of life. Oncologist 7:120–125. doi: 10.1634/theoncologist.7-2-120

5. Bottomley A, Therasse P (2002) Quality of life in patients undergoing systemic therapy for advanced breast cancer. Lancet Oncol 3:620–628. doi: 10.1016/S1470-2045(02)00876-8

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework;Health Technology Assessment;2021-12

2. The Evolution of Clinical Trials in Metastatic Breast Cancer: Design Features and Endpoints That Matter;American Society of Clinical Oncology Educational Book;2020-05

3. The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement: Explanation and Elaboration;Annals of Internal Medicine;2019-11-12

4. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry;The Breast;2018-02